Clene (CLNN) EBITDA Margin (QoQ) (2020 - 2025)
Powered by 
Analysis
Clene (CLNN) EBITDA Margin (QoQ) (2020 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 641.14 Bn | 620.38 Bn | 17.26 Bn |
| 2 | AbbVie | 451.04 Bn | 444.47 Bn | 12.70 Bn |
| 3 | Merck | 357.43 Bn | 350.29 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.73 Bn | 259.04 Bn | 11.24 Bn |
| 5 | Pfizer | 157.52 Bn | 145.82 Bn | 10.94 Bn |
| 6 | Sanofi | 52.14 Bn | 44.76 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 42.88 Bn | 42.88 Bn | - |
| 8 | Incyte | 24.70 Bn | 20.16 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.47 Bn | 18.80 Bn | 683.80 Mn |
| 10 | Clene | 45.69 Mn | 45.69 Mn | 54,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 2.79 Mn |
| Sep 30, 2025 | -1.58 Mn |
| Jun 30, 2025 | -1.68 Mn |
| Mar 31, 2025 | 445,695.00 |
| Dec 31, 2024 | -53,592.00 |
| Sep 30, 2024 | -85,089.00 |
| Jun 30, 2024 | 451,471.00 |
| Mar 31, 2024 | -680,540.00 |
| Dec 31, 2023 | 299,401.00 |
| Sep 30, 2023 | -499,281.00 |
| Jun 30, 2023 | 618,753.00 |
| Mar 31, 2023 | -504,145.00 |
| Dec 31, 2022 | 64,660.00 |
| Sep 30, 2022 | 3.32 Mn |
| Jun 30, 2022 | 559,619.00 |
| Mar 31, 2022 | -3.74 Mn |
| Dec 31, 2021 | 247,008.00 |
| Sep 30, 2021 | -267,978.00 |
| Jun 30, 2021 | -137,271.00 |
| Mar 31, 2021 | 1.51 Mn |